Blood Transfusions and Blood Components (Angelina L. Mirasol, MD) Flashcards

1
Q

Also known as the Blood Services Act of 1994

A

RA 7719

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does RA 7719 emphasize?

A

Voluntary and non-profit collection of blood
Blood donation as a humanitarian act
Provide safe, affordable and equitable distribution of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What must each blood unit be labelled with?

A

ABO and RhD group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risks associated with allogenic red cell transfusion

A

Transfusion reactions
Disease transmission
Immunomodulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Detection, data gathering and analysis of adverse events of blood transfusion

A

Hemovigilance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When should blood transfusion be performed?

A

When the required tests are done and the benefits outweigh the risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F: If possible, transfuse blood components rather than whole blood.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is informed consent for transfusion not needed?

A

Life-threatening emergencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Allows single blood donation to provide treatment for several patients

A

Fractionation of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Blood component that transmits most of the infections present in whole blood

A

Plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Composition of whole blood

A

Hct 40% / 570 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications for the use of whole blood

A

Symptomatic anemia with large volume deficiet (except severe chronic anemia)
Loss of both RBC and plasma volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Viability of Pakced Red Blood Cells (PRBCs)

A

35 days (stored in CPDA-1) to 42 days (stored in AS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Composition of PRBC

A

Hct 55 - 70% / 330 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications for use of PRBC

A

Symptomatic anemia

Hgb < 7 g/dl or Hct <21%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of red blood cell substitutes

A

Fluorocarbon-based synthetic oxygen carriers

Stroma free, cross-linked or polymerized human or nonhuman hemoglobin preparation

17
Q

When are red blood cell substitutes useful?

A

Acute massive blood loss (trauma or major operation)

Patients declining transfusion for religious reasons

18
Q

Contraindications to RBC transfusion

A
  1. Volume expansion when oxygen carrying capacity is adequate
  2. Prophylaxis w/o symptoms of anemia
  3. Enhance sense of well-being
  4. Promote wound healing
19
Q

Indications for platelet transfusion therapy

A

Therapeutic

Prophylactic

20
Q

Guidelines for platelet transfusion

A

P1 - Count <100,000
P5 - Massive transfusion with diffuse microvascular bleeding
P6 - Others

21
Q

Appropriate dose for platelet transfusion therapy

A

1 unit/10 kg body weight (max 8 units)

22
Q

Disorders where platelet transfusion is not useful

A
Drug induced thrombocytopenia
Thrombotic thrombocytopenia purpura
Hemolytic-uremic syndrome
Idiopathic thrombocytopenia purpura
Heparin induced thrombocytopenia
Conditions where platelets are destroyed or not activated
23
Q

Usual adult dose of random donor platelets

A

6 units

24
Q

What increment is expected to be achieved following transfusion with random donor platelets?

A

30,000/uL (each unit expected to raise platelet count by 5,000/uL)

25
Q

Risk of using random donor platelets

A

Associated with septic reaction due to storage at room temperature

26
Q

Expected post-transfusion platelet increased from 1 unit of SDP/Apheresed platelets

A

30,000 uL

27
Q

Adult dose of fresh frozen plasma

A

10 - 20 mL/kg body weight

Standard Dose: 4 - 6 units

28
Q

Expected increase in coagulation factor levels after administration of fresh frozen plasma

A

20%

29
Q

Shelf life of fresh frozen plasma, cryoprecipitate and cryosupernate

A

1 year when frozen at -30 degrees Celsius

30
Q

Indications for use of fresh frozen plasma

A

Control or prevention of bleeding in multiple coagulation defects

31
Q

Fraction of plasma proteins precipitated when FFP is thawed at 4 degrees Celsius

A

Cryoprecipitate

32
Q

Components of the cryoprecipitate

A

VIII, VWF, XIII, fibrinogen, and fibronectin

33
Q

Adult dose of cryoprecipitate

A

10 - 20 units

Note: 1 unit/10kg increases fibrinogen by 7 - 10 mg/dL

34
Q

Indications for use of cryoprecipitate

A

Hemophilia A with bleeding or anticipated surgery
Von Willebrand Disease
Fibrinogen deficiency
Factor XIII deficiency

35
Q

Indications for use of cryosupernate

A

Hemophilia B with bleeding or anticipated surgery
Factor II, VII or X deficiency
Hemorrhage due to coumadin-type drugs

36
Q

Adult dose of cryosupernate

A

1 unit/10 kg BW

37
Q

Most common cause of acute transfusion reactions

A

Transfusion of incompatible blood component

38
Q

T/F: Under no circumstances should blood be stored outside for more than 1 hour prior to transfusion.

A

False

The limit is 30 minutes. No more than 30 mins!